BioCentury
ARTICLE | Distillery Therapeutics

Cancer

September 26, 2018 5:39 PM UTC

Cell culture and mouse studies identified a Wnt/β-catenin pathway inhibitor and p53 activator that could help treat colorectal cancer. Screening of a small molecule library in a human cell-based assay...

BCIQ Target Profiles

Beta-catenin (CTNNB1)

p53